ABSTRACT
PURPOSE: To evaluate CT reconstruction parameters to improve stent lumen visualization in vitro. MATERIAL AND METHODS: 12 latest superficial femoral artery (SFA) stents were placed in a vessel phantom (diameter 4.7 mm, intravascular attenuation 250 HU, extravascular density 50 HU). Stents were imaged with a 128-slice scanner (SOMATOM Definition Flash, Siemens, Germany) with standard parameters: 120 kV, 200 mAs, collimation 128mm × 0.6mm. Different reconstruction parameters were evaluated: B26f, B30f, B45f, B46f and B60f kernel; slice thickness of 0.6, 2.0 and 5.0mm. To measure visualization characteristics, stent lumen diameter and intraluminal attenuation were assessed. RESULTS: Best stent lumen visualization could be obtained using the B46f kernel (p<0.001). The visible stent lumen ranged from 66.4% to 83.3% with a mean diameter of 77.7 ± 4.6%. Nitinol stents showed a significant improved lumen visibility compared to the cobalt-chromium stent (p = 0.02). The most realistic lumen attenuation was achieved using the B46f kernel with a mean attenuation of 259.3 ± 8.9 HU. The visible lumen diameter in protocols with 5mm slice thickness was significantly lower (70.0 ± 4.9%) compared to thinner slices (p<0.001). CONCLUSION: CTA of SFA stents should be reconstructed with a slice thickness of 2.0mm and a B46f kernel to achieve best image quality and to become more sensitive to exclude instent restenosis.
Subject(s)
Angiography/methods , Femoral Artery/diagnostic imaging , Phantoms, Imaging , Stents , Tomography, X-Ray Computed/methods , Alloys , Chromium Alloys , Cobalt , Humans , In Vitro Techniques , Radiographic Image Interpretation, Computer-AssistedABSTRACT
PURPOSE: To estimate the effective dose of cardiac CT with different dose saving strategies dependent on varying heart rates. MATERIALS AND METHODS: For dose measurements, an Alderson-Rando-phantom equipped with thermoluminescent dosimeters was used. The effective dose was calculated according to ICRP 103. Exposure was performed on a 128-slice single source scanner providing a rotation time of 0.30s and standard protocols with 120 kV and 160 mAs/rot. Protocols were evaluated without ECG-pulsing, with two different ECG-pulsing techniques, and automated exposure control with a simulated heart rate of 60 and 100 beats per minute. RESULTS: Depending on different dose saving techniques and heart rate, the effective whole-body dose of a cardiac scan ranged from 2.8 to 9.5 mSv and from 4.3 to 16.0 mSv for males and females, respectively. The radiation-sensitive breast tissue in the primary scan range results in an increased female dose of 66.7 ± 6.0%. Prospective triggering has the greatest potential to reduce the effective dose to 27.8%, compared to a comparable scan protocol with retrospective ECG-triggering with no ECG-pulsing. Furthermore, the heart rate influences the radiation exposure by increasing significantly at lower heart rates. CONCLUSION: Due to this broad variability in radiation exposure of a cardiac CT, the radiologist and the CT technician should be aware of the different dose reduction strategies.
Subject(s)
Body Burden , Coronary Angiography/methods , Radiation Dosage , Radiation Protection/methods , Radiometry/methods , Tomography, X-Ray Computed/methods , Adult , Algorithms , Female , Humans , Male , Reproducibility of Results , Sensitivity and SpecificityABSTRACT
BACKGROUND: CT has become an important role in the differential diagnosis of acute chest pain to exclude an aortic dissection, pulmonary embolism and acute coronary artery syndrome. However, the additional radiation exposure is a cause of concern and dose saving strategies should be applied, if possible. PURPOSE: To estimate effective dose of retrospective gated and prospective ECG-triggered triple-rule-out computed tomography angiography (TRO-CTA). MATERIAL AND METHODS: An Alderson-Rando-phantom equipped with thermoluminescent dosimeters was used for dose measurements. Exposure was performed on a 128-slice single source scanner. The following scan parameters were used (retrospective ECG-gated): 120 kV, 190 mAs/rot., collimation 128x0.6 mm, rotation time 0.3 s. Protocols with a simulated heart rate (HR) of 60 and 100 bpm were performed using the standard ECG-pulsing as well as MinDose. Additionally, a prospective triggered TRO-CTA was acquired (HR 60 bpm). RESULTS: The estimated effective dose of retrospective ECG-gated TRO-CTA ranged from 7.4-13.4 mSv and from 10.1-17.5 mSv for men and women, respectively. Due to radiosensitive breast tissue, women received a significant increased effective dose of up to 64.7% ± 0.03% (p = 0.028) compared to men. MinDose reduces radiation exposure of up to 33.0% ± 6.5% in comparison to standard ECG-pulsing (p < 0.001). The effective dose increased significantly with lower heart rates (p < 0.001). Prospective ECG-triggered TRO-CTA showed an effective dose of 5.9 mSv and 8.2 mSv for men and women, respectively. Compared to retrospective ECG-gated TRO-CTA a significant dose reduction was observed (p < 0.001). CONCLUSION: Due to the significant different dose exposure, scan protocols should be specifically adapted in a patient- and problem-oriented manner.
